BONANNI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 10.538
EU - Europa 8.436
AS - Asia 7.051
SA - Sud America 1.338
AF - Africa 100
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 17
Totale 27.502
Nazione #
US - Stati Uniti d'America 10.319
SG - Singapore 2.823
CN - Cina 2.177
IT - Italia 2.140
IE - Irlanda 1.342
UA - Ucraina 1.143
BR - Brasile 1.097
TR - Turchia 805
GB - Regno Unito 801
SE - Svezia 773
DE - Germania 659
FR - Francia 563
VN - Vietnam 411
IN - India 379
FI - Finlandia 330
RU - Federazione Russa 245
CA - Canada 128
HK - Hong Kong 96
AR - Argentina 84
JP - Giappone 71
PL - Polonia 71
NL - Olanda 70
MX - Messico 69
AT - Austria 65
BD - Bangladesh 57
ES - Italia 51
CZ - Repubblica Ceca 47
ZA - Sudafrica 46
EC - Ecuador 41
IQ - Iraq 33
IR - Iran 29
ID - Indonesia 28
BE - Belgio 26
CL - Cile 25
CO - Colombia 25
KR - Corea 25
LU - Lussemburgo 25
PK - Pakistan 21
EU - Europa 19
VE - Venezuela 19
LT - Lituania 16
PE - Perù 16
PY - Paraguay 16
MA - Marocco 14
RO - Romania 14
IL - Israele 13
UZ - Uzbekistan 13
EG - Egitto 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
AU - Australia 9
JO - Giordania 9
TN - Tunisia 9
AZ - Azerbaigian 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
PT - Portogallo 8
NZ - Nuova Zelanda 7
BO - Bolivia 6
KE - Kenya 6
NO - Norvegia 6
SA - Arabia Saudita 6
OM - Oman 5
GY - Guiana 4
HU - Ungheria 4
KZ - Kazakistan 4
LB - Libano 4
UY - Uruguay 4
BG - Bulgaria 3
DZ - Algeria 3
GR - Grecia 3
JM - Giamaica 3
MY - Malesia 3
NP - Nepal 3
PA - Panama 3
SC - Seychelles 3
SM - San Marino 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AL - Albania 2
HN - Honduras 2
NG - Nigeria 2
PH - Filippine 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
GD - Grenada 1
GH - Ghana 1
GT - Guatemala 1
KG - Kirghizistan 1
Totale 27.488
Città #
Singapore 2.062
Chandler 1.491
Jacksonville 1.342
Dublin 1.320
Ashburn 670
Princeton 621
Dallas 599
Southend 570
Beijing 555
Izmir 418
Nanjing 407
Dearborn 290
Los Angeles 279
Wilmington 273
Santa Clara 259
The Dalles 242
Cambridge 210
Chieti 200
Altamura 195
Munich 191
New York 190
Tongling 159
Ho Chi Minh City 145
Ann Arbor 144
Nanchang 139
Buffalo 118
Boardman 115
Pescara 112
Redondo Beach 112
Rome 111
São Paulo 111
Hong Kong 93
Milan 87
Woodbridge 75
Helsinki 74
Hanoi 71
Hebei 69
Tianjin 69
Washington 67
Shenyang 61
Kunming 57
Turku 54
Warsaw 53
Brooklyn 51
Grevenbroich 49
Hefei 49
Nuremberg 49
Tokyo 48
Houston 47
London 46
Jiaxing 44
Norwalk 44
Toronto 44
Denver 43
Belo Horizonte 41
Changsha 41
Seattle 41
Chicago 40
Montreal 38
Council Bluffs 35
Jinan 35
Chennai 34
Dong Ket 34
Frankfurt am Main 34
Hangzhou 32
Johannesburg 31
Brno 30
Poplar 30
Stockholm 30
Florence 29
Vienna 28
Orem 27
Augusta 26
Capurso 26
Mexico City 26
Atlanta 24
Falls Church 24
Rio de Janeiro 24
San Francisco 24
Brussels 23
Lanzhou 23
Pune 23
Amsterdam 22
Leawood 22
Ardabil 21
Boston 21
Mumbai 21
Phoenix 21
Seoul 21
Biên Hòa 20
Paris 20
Changchun 19
Haiphong 19
Manchester 19
Ningbo 19
Brasília 18
Naples 18
Porto Alegre 17
San Mateo 17
Charlotte 16
Totale 16.198
Nome #
Emergenza neurologica - tempesta distonica: diagnosi e terapia 465
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 322
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 298
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 265
Pre-trattamento antiematico per Test/terapia all'apomorfina 180
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 156
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 154
GABA levels in the ventromedial prefrontal cortex during the viewing of appetitive and disgusting food images 153
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 150
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 145
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 142
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 141
Functional and neurochemical interactions within the amygdala-medial prefrontal cortex circuit and their relevance to emotional processing 141
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 141
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 140
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 138
GABA content within the ventro-medial prefrontal cortex is related to trait anxiety 137
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 135
Progetto atrofia multisistemica: risultati preliminari. 134
Akinetic crisis in Dementia with Lewy Bodies 134
Monitoraggio in vivo, con Risonanza Magnetica Morfologica (MRI) e Spettroscopica (H-MRS), dei cambiamenti metabolici e morfologici sulla via nigro-striatale indotti dal trattamento con PSI in un modello animale di Parkinson 132
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 132
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 131
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 131
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 129
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 128
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 127
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 125
Abnormal BAEP and internal auditory canal MRI in intracranial hypotension 124
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 123
Bipallidal lesions induce delayed and progressive parkinsonism 123
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 123
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 123
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 122
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 122
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 122
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 120
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 119
ALZHEIMER DISEASE AND LEWY BODY DEMENTIA CAN BE DISTINGUISHED BY THE CYTOMETRIC IDENTIFICATION OF A NOVEL DIAGNOSTIC BIOMARKER 119
Improving diagnostic accuracy of DLB: An MRI study 119
GABA content within medial prefrontal cortex predicts the variability of fronto-limbic effective connectivity 119
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 118
Attention network in AD and DLB patients: a resting fMRI study. 118
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 117
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 117
Correlazione tra dinamica del repertorio TCR e reattività alla proteina basica della mielina (MBP) nel sangue periferico di pazienti con Sclerosi multipla esacerbante/remittente 116
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 116
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 115
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 115
Autoscopic phenomena: case report and review of literature. 114
Regulation of Socs-1 and Gerp/TRIM-8 expression on multiple sclerosis patients undergoing interferon beta-1 treatment 114
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 113
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 113
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 113
Instabilità posturale nel Parkinson non farmaco-responder 112
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 112
A Critical Review of Alien Limb-Related Phenomena and Implications for Functional Magnetic Resonance Imaging Studies 112
Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report 109
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 109
TRATTAMENTO CON TOSSINA BOTULINICA DELLA DISTONIA ASSIALE LATERALE NEL PARKINSONISMO. 108
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 108
Mitochondrial Involvement in Neurodegenerative Dementia 107
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 106
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation. 106
Pathological Gambling in PD is reduced by Amantadine 106
A subtle mimicker in emergency department: Illustrated case reports of acute drug-induced dystonia 106
Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase 105
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 105
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 105
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 105
Visual Hallucinations in PD and Lewy body dementias: Old and new hypotheses 104
Atrofia Multisistemica: approccio diagnostico multidisciplinare 104
Serial analysis of peripheral blood T cell receptor (TCR) V beta repertoire by RT-PCR/SSCP in patients with multiple sclerosis (MS) and healthy controls. 104
Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study 104
Rehabilitation program based on sensorimotor recovery improves the static and dynamic balance and modifies the basal ganglia neurochemistry: A pilot 1H-MRS study on Parkinson's disease patients 104
Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction 104
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 103
Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study. 103
Dynamics of peripheral blood T cell receptor V beta repertoire in patients with relapsing-remitting multiple sclerosis. 103
Catamenial end-off dose in Parkinson's disease 103
Brainstem evoked potentials and magnetic resonance imaging abnormalities in differential diagnosis of intracranial hypotension. 103
Somatic symptoms disorders in Parkinson's disease are related to default mode and salience network dysfunction 102
Interictal Heart Rate Variability Analysis Reveals Lateralization of Cardiac Autonomic Control in Temporal Lobe Epilepsy 102
Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel 102
Valutazione dei potenziali evocativi visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 101
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 101
Relevance of subcortical visual pathways disruption to visual symptoms in dementia with Lewy bodies. 101
Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease 101
The pharmacology of visual hallucinations in synucleinopathies 101
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 101
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 100
Prevalenza dei disturbi motori e non motori nella popolazione di pazienti con demenza a corpi di Lewy afferente al nostro centro per i disordini del movimento e le demenze. 100
Mixed resting and postural tremor with overflow in orthostatism is observed in PDD/DLB patients 100
Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study 100
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 100
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease. 99
AMANTADINE EFFECT ON PARKINSON'S DISEASE IMPULSE CONTROL DISORDER 99
Paradoxical kinesia in parkinsonian patients surviving earthquake. 99
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 99
L’ecografia transcranica nello studio del parenchima cerebrale: la nostra casistica 98
Totale 12.549
Categoria #
all - tutte 120.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.013 0 0 0 0 0 324 44 53 132 207 154 99
2021/20221.366 33 20 62 158 77 45 46 117 121 53 198 436
2022/20234.307 353 597 289 438 382 841 278 297 546 60 109 117
2023/20242.361 175 71 169 95 148 655 499 130 37 91 51 240
2024/20255.465 303 919 827 146 155 236 254 286 468 348 612 911
2025/20265.539 959 442 1.252 1.654 1.123 109 0 0 0 0 0 0
Totale 28.430